Michael Honer
Michael Honer publishes mostly in Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Neuroscience and Neuropharmacology Research, Medical Imaging Techniques and Applications and Radiopharmaceutical Chemistry and Applications.
- World rank
- #307,009 of 7,710,434 ranked researchers
- Rank in Switzerland
- #5,860 of 80,918
- Works
- 170
- Citations
- 6.1k
- Citations per work
- 35.8
What does Michael Honer research?
Michael Honer's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6840.2%
- Life Sciences5230.5%
- Biochemistry, Genetics and Molecular Biology2715.7%
- Neuroscience2514.8%
- Health Sciences5029.3%
- Medicine5029.3%
- 1Radiology, Nuclear Medicine and Imaging17% of their works
- 2Molecular Biology16% of their works
- 3Cellular and Molecular Neuroscience15% of their works
- 4Pharmacology5% of their works
- 5Physiology4% of their works
- 6Neurology4% of their works
Research topics
- Neuroscience and Neuropharmacology Research
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Receptor Mechanisms and Signaling
- Cannabis and Cannabinoid Research
- Alzheimer's disease research and treatments
- Monoclonal and Polyclonal Antibodies Research
- Nicotinic Acetylcholine Receptors Study
Which keywords describe Michael Honer's research?
The keywords of their largest research topics: Neurological Disorders, Neurotransmission, Synaptic Plasticity, Crystal Structure, Imaging, PET/CT, PET Imaging and Radiopharmaceuticals.
- Nicotinic Acetylcholine Receptors
- Therapeutic Antibodies
- Tau Pathology
- Endocannabinoid System
- Signal Transduction
- Radiopharmaceuticals
- PET/CT
- Crystal Structure
- Neurotransmission
- Neurological Disorders
- Synaptic Plasticity
- Imaging
- PET Imaging
- G-Protein-Coupled Receptors
- Cannabinoid Receptors
- Amyloid Hypothesis
- Fc Receptors
- Neuronal Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Neurological Disorders462 topics
- Neurotransmission341 topic
- Synaptic Plasticity341 topic
- Crystal Structure232 topics
- Imaging221 topic
- PET/CT221 topic
- PET Imaging191 topic
- Radiopharmaceuticals191 topic
- G-Protein-Coupled Receptors151 topic
- Signal Transduction151 topic
- Cannabinoid Receptors121 topic
- Endocannabinoid System121 topic
- Amyloid Hypothesis111 topic
- Tau Pathology111 topic
- Fc Receptors101 topic
- Therapeutic Antibodies101 topic
- Neuronal Signaling81 topic
- Nicotinic Acetylcholine Receptors81 topic
Where does Michael Honer work?
Michael Honer's main affiliation in the publication record is Roche (Switzerland), Switzerland.
How many publications and citations does Michael Honer have?
OpenAlex counts 170 works and 6,081 citations for Michael Honer, an h-index of 41, ranking #307,009 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Honer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.